Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record for the MEDI0457 and durvalumab study is now displayed, including its study design, eligibility criteria, locations, outcome measures, and posted documents, instead of an error page.
    Difference
    73%
    Check dated 2026-11-08T13:08:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:26:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology changes during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page.
    Difference
    1%
    Check dated 2026-10-25T13:24:58.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the study page remained inaccessible.
    Difference
    0.2%
    Check dated 2026-10-18T13:39:27.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:45:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error message with a 403 header and a Home link, replacing the expected study record content.
    Difference
    0.5%
    Check dated 2026-09-27T17:56:14.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.